Roche Holding AG
RHHVF
$466.28
-$0.41-0.09%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.21B | 72.52B | 71.13B | 68.88B | 68.74B |
| Total Other Revenue | 2.22B | 2.20B | 2.19B | 2.14B | 2.16B |
| Total Revenue | 76.43B | 74.73B | 73.32B | 71.02B | 70.90B |
| Cost of Revenue | 19.53B | 18.97B | 18.48B | 17.92B | 17.88B |
| Gross Profit | 56.90B | 55.76B | 54.84B | 53.11B | 53.02B |
| SG&A Expenses | 16.64B | 16.25B | 15.94B | 15.51B | 15.54B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -62.98M | 101.91M | 270.95M | 151.11M | 11.54M |
| Total Operating Expenses | 51.23B | 50.45B | 49.88B | 48.56B | 48.63B |
| Operating Income | 25.20B | 24.28B | 23.44B | 22.46B | 22.26B |
| Income Before Tax | 20.38B | 17.79B | 15.24B | 13.98B | 13.35B |
| Income Tax Expenses | 3.81B | 3.54B | 3.28B | 3.06B | 2.96B |
| Earnings from Continuing Operations | 16.57K | 14.25K | 11.96K | 10.92K | 10.39K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.11B | -1.07B | -1.03B | -1.02B | -1.03B |
| Net Income | 15.46B | 13.18B | 10.93B | 9.90B | 9.36B |
| EBIT | 25.20B | 24.28B | 23.44B | 22.46B | 22.26B |
| EBITDA | 28.92B | 27.95B | 27.08B | 25.99B | 25.79B |
| EPS Basic | 19.42 | 16.56 | 13.73 | 12.43 | 11.74 |
| Normalized Basic EPS | 17.17 | 16.55 | 15.99 | 15.21 | 14.96 |
| EPS Diluted | 19.25 | 16.41 | 13.61 | 12.33 | 11.65 |
| Normalized Diluted EPS | 17.02 | 16.42 | 15.87 | 15.10 | 14.87 |
| Average Basic Shares Outstanding | 3.18B | 3.19B | 3.19B | 3.19B | 3.19B |
| Average Diluted Shares Outstanding | 3.21B | 3.21B | 3.21B | 3.21B | 3.21B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 58.14% | 68.17% | 82.22% | 86.17% | 91.97% |